High-content screening has emerged as a new and powerful technique for identifying small-molecule modulators of mammalian cell biology. The authors describe the development and execution of a high-content screen to identify small molecules that induce mitotic arrest in mammalian cancer cells. Many widely used chemotherapeutics, such as Taxol ® and vinblastine, induce mitotic arrest, and the creation of new drugs that also induce mitotic arrest may have tremendous therapeutic value. In their screen, the authors employed a simple DNA stain (DAPI) and a sensitive nonparametric statistical test to identify compounds from an internal collection of~13,000 high-quality lead-like small molecules. Subsequent analysis of 1 active compound indicated that it induces mitotic arrest, assessed using a high-content phosphohistone H3 detection assay, and caused cell proliferation defects in multiple cancer cell lines. The active compound, a quinazolinone originating from a natural product-like subset of the screened compounds, is active in cells at~500 nM and appears to act by inhibiting the polymerization of tubulin. (Journal of Biomolecular
INTRODUCTION
C OMPOUNDS THAT HALT THE CELL CYCLE are some of the most successful and widely prescribed chemotherapeutics in use today. In general, these compounds can be divided into 2 classes: tubulin polymerization modulators and DNA replication antagonists. Tubulin-modulating drugs, such as Taxol ® and vinblastine, act by disrupting tubulin polymerization dynamics, leading to a cellular arrest at the M phase of the cell cycle. 1 After a prolonged period of mitotic arrest, the cells ultimately undergo apoptosis (programmed cell death), and this is thought to be the mode of clinical efficacy. 2 Agents that induce mitotic arrest via tubulin dynamics disruption or via other mechanisms (such as Eg5 inhibition) are sought after, and 1 review article indicates there are more than 21 distinct new chemical entities currently in clinical trials and 11 disclosed compounds in preclinical trials. 3 High-content screening, or image-based screening, has recently emerged as a platform for compound testing for "phenotypic" cell-based assays. [4] [5] [6] [7] Founded on automated microscopy, the technology is based on gathering images of fluorescently stained mammalian cells, image analysis to identify individual cells, and then measurement of the signal from the individual cells. 5 In a typical data set, hundreds of cells are measured per well, and each cell has a multitude of measurements associated with it. The spatial information captured within the image enables unique assays, such as the nuclear translocation of Forkhead protein, 8 measurement of G-protein-coupled receptor (GPCR) recycling using a β arrestin-GFP fusion, 9 centrosome duplication, 10 or the identification of wound-healing inhibitors. 11, 12 In addition, measuring individual cells offers a highly sensitive method to analyze up-or down-regulation of pathways or simply changes in staining intensity of commonly used dyes. 13, 14 This technique in particular has been used to create large data sets using hundreds of welldefined compounds enabling the characterization of an unknown compound by comparison or hierarchical clustering. 5, 15 Our interest in identifying compounds that induce mitotic arrest, via interaction with tubulin and through other modes of action, led us to develop a high-content assay based on chromatin staining. In this assay, we used chromatin condensation as a proxy for mitosis and applied a sensitive statistical test, the Kolmogorov-Smirnov (KS) test, to identify treated wells that cause an increase in the percentage of cells in mitosis. The statistical test is straightforward to apply, generally applicable to all high-content assays, and is plate based, allowing easy implementation during screening and EC 50 determinations for follow-up work. We screened a proprietary and well-characterized set of compounds and herein describe the identification and characterization of 1 small molecule that induces mitotic arrest and appears to act by inhibiting tubulin polymerization.
MATERIALS AND METHODS

Compound libraries and compound quality control
All small molecules were stored as 100% DMSO (v/v) stock solutions at 30 mM or 10 mM at both 4°C and -20°C. Compounds were purified using ArQule's high-throughput preparative highperformance liquid chromatography (HPLC) platform, a component of our AMAP (Automated Molecular Assembly Plant) technology platform. 16, 17 Compound quality was checked for purity using HPLC UV and evaporative light-scattering detection (ELSD) traces and for correct mass using mass spectrometry. Taxol ® , vinblastine, and nocodazole were all purchased from Sigma (http:// www.sigmaaldrich.com); ARQ 501 was made in house.
Cells and cell culture
A549, DU-145, HT-29, and MDA-MB-231 cancer cells were purchased from the ATCC (http://www.atcc.org). SF-268 cells were acquired from the National Cancer Institute (NCI; http:// www.nci.nih.gov). Human mammary epithelial cells (HMEC) were purchased from Cambrex.
Cells were maintained in a 37°C, 5% CO 2 incubator and cultured using aseptic technique in sterile conditions. All cells were adherent cells and subcultured using trypsinization. All cancer cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (4.5 g/L glucose) supplemented with 15% (v/v) heatinactivated fetal bovine serum (FBS), 10 mM L-glutamine, and 10 mM HEPES. HMEC cells were maintained in media recommended by Cambrex (http://www.cambrex.com).
High-content assays
A549 cells were seeded in black-walled, clear-bottom 96-well plates (ViewPlates, PerkinElmer, http://www.perkinelmer.com) and incubated for 16 to 24 h. Test compounds diluted in DMSO, either from library screening plates or serial dilution plates, were further diluted in complete media and then added to cells; the overall dilution in media was 300-fold, and the final DMSO concentration was 0.33% (v/v), with a final compound concentration ranging between 100 µM and 5 nM. All liquid-handling procedures were completed using a Rapid Plate 384 accessed by a Twister II robotic arm (Caliper Life Science, http://www.caliperls.com); a plate washer (Biotek 405XL, http://www.biotek.com) and an automated incubator (Caliper Life Science) were also integrated with the same Twister II. Eighteen hours after compound addition, a 1:1 mixture of Mirsky's fixative parts A (10×) and B (10×) (National Diagnostics, HS-102, http://nationaldiagnostics.com) was added directly to the culture medium, resulting in a 1× final concentration of fixative. Ninety minutes later, the plates were washed into phosphate-buffered saline (PBS). For screening, DAPI (Invitrogen DS21490, http://www.invitrogen.com) stain was added to the plates to a final concentration of 1 µg/mL, and then each well was overlaid with mineral oil to prevent evaporation. For antibody staining, the fixed and washed plates were blocked and the cells permeabilized with 0.1% bovine serum albumin (BSA; w/v) and 0.1% Triton X-100 (v/v) in PBS for 0.5 to 2 h. Plates were washed into PBS, and antibody solution in PBS was added such that the final concentrations were 1:300 dilution of primary antibody (anti-pH3; Cell Signaling Technology, 9706, http://www.cellsignal .com), 0.1% BSA (w/v), and 0.1% Triton X-100 (v/v). The primary antibody was incubated in the plates for 16 to 24 h at 4°C. Plates were washed into PBS, and antibody solution in PBS was added such that the final concentrations were 1:300 dilution of secondary antibody (anti-mouse Alexa 488, Molecular Probes, A11029, http://www.invitrogen.com), 1 ug/mL DAPI, 0.1% BSA (w/v), and 0.1% Triton X-100 (v/v). Plates were incubated for 1 to 2 h at room temperature. Plates were washed into PBS, and wells were overlaid with mineral oil to prevent evaporation.
Imaging and image analysis were carried out using a Beckman-Coulter/Q3DM EIDAQ100 (http://www.beckmancoulter.com) instrument equipped with a Twister II for automated plate delivery. Four images per well were captured, and DAPI channel images were taken with 16.6-ms/0% gain exposure settings and pH3 images taken with 300-ms/80% gain setting. Automated cell identification and measurement extraction were also carried out within the software using standard settings. Resulting raw data were processed for the KS score using Pipeline Pilot 4.1 (Scitegic, Inc., http://www.scitegic.com) with a custom written software component to calculate KS values. The processed KS score values were analyzed using Activity Base and XLfit software suite (IDBS, Inc., http://www.idbs.com). EC 50 values were calculated from a 4parameter dose-response model fit to the data with nonlinear regression analysis, where the EC 50 value equals the concentration at which the inflection point of the fitted model is reached.
Cell proliferation assay
Cell proliferation was determined by measuring the activity of dehydrogenase enzymes in metabolically active cells using the tetrazolium compound MTS. The assay was performed as described in Promega Technical Bulletin No. 169 (CellTiter 96 Aqueous Non-Radioactive Cell Proliferation Assay, http:// www.promega.com). Briefly, cells were seeded in 96-well plates and incubated for 16 to 24 h; test compounds were serially diluted in DMSO, further diluted in cell culture media, and then added to cells (final DMSO concentration of 0.33% v/v); cells were incubated in the presence of compound for 72 h; MTS was added to the cells and incubated for 4 h; sodium dodecyl sulfate (SDS) was added to a final concentration of 1.4% (w/v); and absorbance at 490 nm was measured within 2 h using a plate reader. The amount of 490 nm absorbance is directly proportional to the number of living cells in the culture. The IC 50 was defined as the concentration of compound that results in a 50% reduction in the number of viable cells as compared to control wells treated with DMSO only (0.33% v/v) and was calculated from a 4-parameter dose-response model fit to the data with nonlinear regression analysis using the Activity Base/XLfit software package.
In vitro tubulin polymerization assay
Tubulin polymerization assays were carried out using the tubulin polymerization assay kit from Cytoskeleton, Inc. (CDS12, http://www.cytoskeleton.com). The assay was carried out following the manufacturer's instructions, except that mineral oil was overlaid immediately before reading the 96-well plate to prevent evaporation.
RESULTS AND DISCUSSION
Small diverse molecule library
A collection of 13,399 small molecules was assembled from ArQule's compound collection of more than 1,000,000 arrayable compounds. This library is one of the key components within our initiative to assemble a high-quality screening repository. Compounds within this collection are well characterized (qualitycontrolled steps ensure a single pure compound per vessel), and because they are made using ArQule's Automated Mapping Array platform, they are amenable to rapid synthesis of analogs (i.e., hit explosion). Compounds were selected based on lead-likeness filters ( Fig. 1A) and also diversity and availability across our source library. Using our high-throughput chemistry platform, all stores of selected compounds were purified by preparative HPLC chromatography, dried, reweighed, dissolved in DMSO, and analyzed for final purity by HPLC/MS. 16, 17 Shown in Figure 1B is a representation of the library plotting molecular weight against calculated-logP for each compound. This library was dispensed into single-use 96-well plates, stored frozen at -20°C, and used for all subsequent screening activities. All compounds are > 80% pure, judged by UV 214 nm and ELSD, and the major product contains a single mass species of the predicted molecular weight. Spot checks and follow-up work indicate that purity and concentration of nearly all compounds are maintained using our storage methods (data not shown).
Image-based assay for mitotic arrest
To assay small-molecule compounds for mitotic arrest, we chose to use the change in DNA condensation states that cells undergo while progressing through the cell cycle. As a cell goes from G1 through S then G2, its DNA typically has a diffuse nuclear stain. Upon entrance into mitosis, a cell's DNA condenses and organizes itself into chromosome bodies that are necessary to equally separate the DNA into the resulting daughter cells. This phenomenon can be visualized using a fluorescent DNA stain, such as DAPI (4′-6-diamidino-2-phenylindole). The condensation of nuclei is visually striking and can be quantitatively measured on a cell-by-cell basis using digital images and cell finding and integration software. Within a population of asynchronously growing cancer cells in culture, a small percentage of the cells (approximately 5% for A549 cells) will be in mitosis at any given time. However, when a population of cells is treated with a mitotic arresting agent, such as 250 nM Taxol ® for 18 h, many of the cells (approximately 50% in this case) have an obvious condensed chromatin (shown in Fig. 2B) , and the other 50% appear to be not in M phase or, upon closer inspection, appear to have fragmented nuclei (data not shown). This is typical of Taxol ® treatment and, in our findings, many mitotic arresting agents, although the percentages of cells affected vary depending on the agent. Because of these subtle yet diverse responses, we developed a sensitive statistical test to compare cell populations to untreated cells. Ultimately, we wanted an assay that would be generally applicable and that would return 1 value per well so that we could rank compounds from screening campaigns and calculate EC 50 concentration from dose-response experiments.
Shown in Figure 2A is a schematic detailing the process we use to assay compounds for chromatin condensation. For all imagebased assays described here, we used A549 cells because they are a relatively easy-to-handle carcinoma cell line and disperse well when plated, which allows interrogation of individual cells rather than clumps of cells. The A549 cells are plated into flat, clearbottom 96-well plates on day 0, and then compound, previously solubilized in DMSO and further diluted in culture medium, is added on day 1. The cells are then incubated with compound for 18 h and fixed using a relatively nontoxic aldehyde-based fixative called "Mirsky's fixative" (National Diagnostics), which we could add directly to the media. We have found that this fixative is easy to use, avoids the environmental and safety issues associated with formaldehyde, and is compatible with all our antibody staining procedures tested to date. After fixation, the cell plates were washed into PBS, DAPI was added, and the wells were covered with mineral oil to prevent evaporation. The plates were imaged over the next several hours or days later.
As a base platform for image acquisition, we used the Beckman-Coulter EIDAQ100 instrument, an automated microscope that includes a high-speed piezo-driven auto-focus. We have found that the EIDAQ100 instrument generally takes extremely clear images due to the advanced auto-focusing routines. However, in general, the instrument has problems with robustness and frequently needs restarting due to hardware or software problems. We took 4 images per well, typically capturing 150 to 300 cells in a DMSO-treated well and 50 to 100 cells in a well treated with our positive control compound Taxol ® . The EIDAQ100 software analyzed the images generated from each well, finding individual cell nuclei or clumps of nuclei using the DAPI stain images and then measured pixel value intensities within identified areas. The software returned a list of all cells identified within a well and its associated pixel measurements (i.e., average of the pixels, standard deviation of the pixels, location on the center pixel, etc.). From the DAPI-stained image analysis, we found that we could distinguish mitotic cells using the average pixel value per cell. Similarly, for other antibody staining assays, in which we were measuring upand down-regulation of an epitope's signal, we found that the average pixel value per cell was also a robust measure.
From the EIDAQ100 output, we created a data pipeline and statistical test to compare the test compound wells within a plate to DMSO control wells and return a single value per well. The KS test compares 2 populations and returns a value between 0 and 1 describing whether the populations are identical (0) or distinct (1). 18 A more complete review of the KS test and its application can be found in Giuliano et al. 19 Briefly, the test measures the maximal distance between 2 distributions by overlaying cumulative histograms and measuring the largest percentage difference between the 2. The test is independent of scale and does not assume any model distribution associated with the data (i.e., a normal distribution or a lognormal distribution), making it amenable to the complex distributions found with high-content data. The test is also independent of population size, which is an important factor when dealing with anticancer compounds that are frequently cytotoxic and reduce cell number. In preliminary studies, we found that when 2 DMSO wells were compared, using the average pixel per . Plotted in log scale on the x-axis is the concentration of Taxol ® in nanomolars. Plotted on the y-axis is the KS score described in the text. Triplicate data points were averaged, and then a dose-response curve was fitted to the resulting data. (Error bars are the standard deviation of the measurements.) cell as an input measure, the KS test returned a value between 0.05 and 0.2. This range is effectively the background for the assay, and we incorporated a background subtraction method to make our results more meaningful (Fig. 3) . We first calculated KS values for all DMSO control wells compared to each other and then took the average of the DMSO-DMSO comparisons as a background measurement. We then calculated KS values for a given test well, comparing it to all DMSO wells individually. Finally, we took the average of the given test well comparisons and subtracted the background measurement to arrive at our final measurement. We dubbed the measurement the "KS score," and it effectively measures, very sensitively, whether there is a difference between the test well cell population and the DMSO well cell populations within an assay plate. A score of 0 indicates no change by a test compound relative to the DMSO controls, and a score of 1 indicates that every cell in the test population is different from the DMSO control populations. Practically, we have found for the DAPI staining assay that KS scores greater than 0.2 indicate a significant response that can be visually verified. For other antibody staining assays, the threshold value needs to be empirically determined, and a KS score of 0.2 acts as a good starting point for visual reconfirmation. Because the score is focused on 0 and has a maximum of 1, it is straightforward for assay developers to work with and is similar to a percentage inhibition measure. Another advantage of the KS score is that it is generally applicable to most imagebased assays. Here we have applied the same test to an antibody staining assay, which measures the increase in cellular abundance of the phosphohistone H3 epitope. We have also found that it is applicable with several other antibody stains (data not shown). It is also noteworthy that recently, other groups have used the KS test with a high-content screening in a similar fashion. In one implementation, the test is used to distinguish specific biological markers involved with p53 action. 19 In the other, the test is used to create a common metric (the titration invariant similarity score or TISS) for clustering data from many high-content assays crossed against a small collection (100) of pharmaceutically active small molecules. 15 To our knowledge, this work is the 1st implementation of a KS test in a high-throughput compound screen, and our process differs from these methods in the simplified background subtraction routine.
We tested whether the KS score could adequately detect chromatin condensation change using Taxol ® and other mitotic arrest-inducing agents. Figure 2C shows a dose-response curve where the x-axis is the concentration of Taxol ® in a log scale and the y-axis is the KS score. The resulting data were curve fitted, and the EC 50 determination was 18.5 nM, which is consistent with previous measurements. 1 The dose-response curve plateaus at 0.6, which is also consistent with the images in which approximately 50% to 70% of the cells have the chromatin condensation phenotype. Other mitotic-arresting agents, including vinblastine and nocodazole, were also tested and gave EC 50 s similar to those previously reported (data not shown).
Screening the library with a high-content chromatin condensation assay
We screened the compound collection at 10 µM final concentration, in duplicate, using the DAPI stain assay described above. Within each 96-well plate, we incorporated 8 DMSO negative controls, four 250-nM Taxol ® positive controls, and four 10-µM ARQ 501 positive controls. ARQ 501 is a cell cycle checkpoint activator that is now in phase I clinical trials. [20] [21] [22] [23] We have found that it induces chromatin condensation, and unlike Taxol ® , greater than 90% of the cells within a treated well show chromatin condensation attributes and thus give a higher KS score. Shown in Figure  4A is a scatter plot with all control wells plotted from the entire screen. They are chronologically ordered along the x-axis based on acquisition time, and on the y-axis, the KS score is plotted. DMSO control wells are colored blue, Taxol ® wells are gray, and ARQ 501 wells are red. Also shown in Figure 4A is the Z′ score, a measure of assay reproducibility and usefulness. When using ARQ 501 as a positive control, the Z′ score was 0.7 across the entire screen, indicating that this is a high-quality assay (mean KS score of 0.75 with standard deviation of 0.05). When using Taxol ® , the Z′ score was 0.4 (mean KS score of 0.49 with standard deviation of 0.09), a less robust assay but useful, especially considering that with Taxol ® , only 50% of the cells are in mitotic arrest and the low noise in the DMSO negative control wells.
From the screen, we selected 30 compounds to pursue with reconfirmation. Shown in Figure 4B is a histogram with KS score bins along the x-axis and a count of all test compound wells on the y-axis (each well was screened in duplicate). This graph clearly shows that most test compounds fall below the 0.2 KS score cutoff we used to select wells. The 0.2 KS score cutoff was chosen because it is greater than 10 standard deviations from the DMSO well average; more important, wells with a KS score greater than 0.2 are Screening 11(1); 2006 www.sbsonline.org 25 FIG. 3 . Data analysis method used to generate the Kolmogorov-Smirnov (KS) score, a single value per well, from multiple KS measurements. The 3 steps: background calculation, sample comparison to untreated wells, and background subtraction are described in the text. Note that this method is applicable to most high-content screening assays.
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visually distinct when compared to DMSO-only control wells on the same plate. One advantage of image-based assays is that after selection, the images are easily available to visually confirm whether the hit is due to chromatin condensation or if there is an assay anomaly, such as a scratch on the plate or a piece of dust in the well. The 30 compounds were cherry-picked and assayed from 20 µM to 40 nM in a 10-point, 2-fold dilution series. From this titration data, 24 compounds were active (> 0.2 KS score) at 20 µM or less.
A novel quinazolinone induces mitotic arrest via tubulin destabilization
We characterized one of the hits, a novel quinazolinone (see Fig. 5A for the structure), in several assays. This compound was derived from a subsection of the library composed of synthetic compounds based on natural product templates. [24] [25] [26] We first tested this compound using a cell proliferation assay in a variety of cell lines and 1 primary cell culture. This standard MTS assay can sensitively detect most cell growth perturbations. Table 1 contains the resulting IC 50 measurement from the cell-based proliferation data. With 1 exception, the IC 50 concentration ranged between 0.3 and 1.3 µM in the cancer cell lines, with the average being 0.7 µM. We also found that the IC 50 in HMEC cells was greater than 20 µM, indicating cancer cell targeting specificity.
We then tested whether the compound induces mitotic arrest using the phosphohistone H3 as a marker. We used an antibody that specifically recognizes phosphoylated-Serine 10 on histone H3 and does not recognize nonphosphorylated Serine 10. Histone H3 Serine 10 becomes phosphorylated as cells enter and progress through mitosis, and cells that stain strongly with anti-pH3 are typically in the metaphase or anaphase of mitosis. 27 We used the pH3 antibody with a fluorescently labeled secondary antibody in conjunction with the image-based assay previously described and derived a KS score from a 10-point titration series. Shown in Figure  5B are sample images of cells treated with DMSO control or with 2.5 µM compound. The blue channel is a pseudo-colored image of DAPI-stained cells, and the red channel is a pseudo-colored image of the pH3 staining; in both cases, we have saturated the colors to accentuate the pH3 positive and negative cells. As can be clearly seen in the images, there were many more pH3 positive cells (approximately 8-fold more) in the compound-treated wells than in the DMSO-treated wells. We validated this assay with the pH3 assay using Taxol ® and our KS score and found that it accurately depicted the EC 50 for Taxol ® and correlates with the DAPI assay (data not shown). Figure 5C shows a dose-response curve for the ARQ compound using the pH3-KS score from a 10-point 2-fold titration of compound. This shows that the compound induces mitotic arrest in a dose-dependent fashion. In Table 1 , the EC 50 of compound action for DAPI and pH3 is given at 0.4 and 0.7 µM, respectively. This complements the cell proliferation assay and indicates that the mechanism of the cell proliferation perturbation is very likely caused by the mitotic arrest.
Tubulin polymerization dynamics within the cell are critical for mitosis completion and are frequently targeted by agents that in- duce mitotic arrest. [1] [2] [3] 28, 29 We used a tubulin polymerization assay to determine whether this compound perturbed tubulin dynamics. In this assay, purified tubulin monomer is reconstituted with various components necessary for polymerization, including GTP and glycerol, at 4°C. The reaction is then moved to 37°C, enabling polymerization, and a fluorescent dye that specifically binds only to polymerized tubulin is measured. Over the course of 1 h in an untreated reaction, tubulin polymers form and the fluorescence values increase. In Figure 5D , a chart with time on the x-axis and fluorescent signal on the y-axis is shown; a DMSO-only control well is shown in yellow. Taxol ® , a tubulin polymer stabilizer, shown in turquoise, caused a rapid increase in tubulin polymer formation. Vinblastine, a tubulin destabilizer, caused nearly complete inhibition of tubulin polymer formation. Our compound was tested, and it also shows nearly complete inhibition of tubulin polymer formation. This strongly suggests that this compound interferes directly with tubulin polymerization and that this interaction is the likely cause of mitotic arrest.
CONCLUSIONS
In this article, we have described the creation of a wellcharacterized and lead-like small-molecule library as well as a cell-based high-content assay to identify compounds that induce mitotic arrest. The high-content assay uses a straightforward and inexpensive DNA stain and a new data-processing method, which simplifies data analysis, produces a single scaled measurement per well, and is generally applicable to other high-content assays. We used the proprietary small-molecule collection and assay to identify a novel quinazolinone that induces mitotic arrest via tubulin polymer destabilization. DAPI staining is pseudo-colored blue, and pH3 staining is pseudo-colored red. Both images have been color saturated to accentuate the cells that stain positive for pH3. These images were captured with a 10× objective, and all subsequent digital image handling for both images was conducted in an identical manner. (C) A dose-response plot demonstrating that the compound induces an increase in pH3 staining in a dosedependent manner. Plotted on the y-axis is the Kolmogorov-Smirnov (KS) score applied to the pH3 antibody signal. Duplicate data points were averaged, and then a dose-response curve was fitted to the resulting data. (Error bars are the standard deviation of the measurements.) (D) Representative data from an in vitro tubulin polymerization assay. On the x-axis is time in minutes (60 time points total), and on the y-axis are fluorescence units, which measure the extent of tubulin polymerization in a reaction via a polymer-specific dye. The ArQule compound clearly inhibits tubulin polymerization.
